Shapiro Benjamin

Shapiro Benjamin is listed in filings as Director at Oramed Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including 4 public disclosures. Recent filings connect the profile to Oramed Pharmaceuticals Inc. (ORMP). The current snapshot covers public activity from Jun 9, 2025 to Jan 5, 2026. Reported amounts are shown as $360. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.